Filter By Category
Archives
Share on -
AMOBARBITAL
Generic Name: AMOBARBITAL
ABSTRACT -
Amobarbital is a barbiturate central nervous system depressant with sedative-hypnotic and anticonvulsant properties. It enhances inhibitory gamma-aminobutyric acid (GABA) signalling at the GABAA receptor complex and can produce dose-dependent sedation, hypnosis, anaesthesia, and respiratory depression. Its use is restricted and largely historical or specialist because safer alternatives are available and dependence risk is significant.
DOSAGE -
Dosage should be determined only by a qualified healthcare professional.
Use is controlled and should follow local regulations, product labeling, and hospital protocol.
Dose must be individualised according to indication, age, weight, clinical response, respiratory status, and concomitant CNS depressants.
Avoid self-administration and avoid abrupt discontinuation after repeated use.
SIDE EFFECTS–
- Possible side effects include:
- Drowsiness
- Dizziness
- Impaired coordination
- Confusion
- Respiratory depression
- Hypotension
- Nausea or vomiting
- Paradoxical agitation
- Dependence, tolerance, and withdrawal
- Overdose may cause coma, shock, or death.
ALLRGIC REACTIONS–
- Hypersensitivity to amobarbital or other barbiturates may occur.
- Symptoms may include rash, urticaria, fever, facial swelling, breathing difficulty, or severe skin reactions.
- Important: Patients who develop allergic symptoms should seek urgent medical care and avoid future barbiturate exposure unless directed by a specialist.
DRUG INTERACTIONS–
- Alcohol, opioids, benzodiazepines, sedating antihistamines, and other CNS depressants can cause dangerous additive sedation and respiratory depression.
- Amobarbital may induce hepatic enzymes and reduce the effect of certain medicines, including some anticoagulants, contraceptives, corticosteroids, and antiepileptic drugs.
- MAO inhibitors and other sedatives require caution.
- Patients should inform clinicians about all medicines, supplements, and substance use.
PREAUTIONS–
- Avoid in severe respiratory depression, significant hepatic disease, acute intermittent porphyria, and uncontrolled substance-use disorder unless specialist risk-benefit assessment supports use.
- Use caution in elderly or debilitated patients.
- Pregnancy and breastfeeding require specialist evaluation due to neonatal respiratory depression and dependence risks.
- Do not drive or operate machinery after use.
WARNINGS –
- Amobarbital can cause fatal overdose, respiratory depression, dependence, and withdrawal seizures.
- Do not combine with alcohol or other sedatives unless specifically supervised.
- Abrupt cessation after repeated use may be dangerous.
- Keep securely stored and out of reach of children.
Share on -
. Developed by